Field Medical Closes $40 Million Series A Financing to Redefine Pulsed Field Ablation for Ventricular Tachycardia

CARDIFF-BY-THE-SEA, Calif., April 21, 2025 /PRNewswire/ -- Field Medical Inc., a pioneer in cardiac pulsed field ablation (PFA) technology, today announced the successful closing of $40 million in Series A financing. The round includes $20 million in new capital and the conversion of $20 million in seed-round debt. Participants include several leading strategics, venture capital firms and family offices, with multiple seed investors reinvesting – underscoring strong confidence in the company's initial focus on ventricular tachycardia (VT) and the broader versatility of its technology.

Read the full press release here.